Dezhan Healthcare Company Limited (SHE:000813)
China flag China · Delayed Price · Currency is CNY
3.620
0.00 (0.00%)
Mar 10, 2026, 3:04 PM CST

Dezhan Healthcare Company Company Description

Dezhan Healthcare Company Limited engages in the research and development, manufacture, and sale of cardiovascular and cerebrovascular drugs in the People’s Republic of China.

The company offers atorvastatin calcium tablets, amlodipine atorvastatin calcium tablets, trimetazidine hydrochloride capsules, amiodarone hydrochloride tablets, as well as other drugs, including famciclovir tablets, azathioprine tablets, and hydroxyurea tablets and colchicine tablet.

It also involved in the provision of biological peptides, industrial hemp, and medical service business.

The company was founded in 1980 and is based in Beijing, the People’s Republic of China.

Dezhan Healthcare Company Limited
Country China
Founded 1980
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 1,054
CEO Wei Liu

Contact Details

Address:
Bona Building
Beijing, 100027
China
Phone 86 10 6585 8557
Website dezhanhealthcare.com

Stock Details

Ticker Symbol 000813
Exchange Shenzhen Stock Exchange
Fiscal Year January - December
Reporting Currency CNY
ISIN Number CNE000000VV8
SIC Code 2200

Key Executives

Name Position
Zheming Wei Chairman and Acting Secretary
Wei Liu Co-Chairman and GM
Jinghong Zhang Deputy General Manager
Ling Wu Chief Financial Officer
Lang Chen Accounting Supervisor
Ye Liu Chief Scientist
Tao Gao Deputy GM and Secretary of the Board